MentionFox
Home › Stakes › Firefly Neuroscience, Inc.
5%+ stakes · Schedule 13D and 13G

Firefly Neuroscience, Inc.: 5%+ holders

Who has reported owning 5% or more of Firefly Neuroscience, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more1
Filings7
Latest filing2026-01-30

Firefly Neuroscience, Inc. has 7 Schedule 13D or 13G filings on record since 2025-10-15. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Windsor Private Capital LP5%605,421SCHEDULE 13D/A, 2026-01-302026-01-28
Arena Investors, LP0%0SCHEDULE 13G/A, 2025-11-142025-03-31

Purpose of Transaction (Item 4)

Windsor Private Capital LP

As further described in Item 5(c) below, the Reporting Persons sold an aggregate of 147,300 Common Shares between December 31, 2025 and January 30, 2026. As a result of the transactions described herein, the Reporting Persons have ceased to be the beneficial owners of more than 5% of the outstanding Common Shares, as disclosed on the cover pages of this Amendment No. 6. Accordingly, the filing of this Amendment No. 6 constitutes an exit filing for the Reporting Persons.Item 4 of the SCHEDULE 13D/A filed 2026-01-30

Timeline

FiledHolderPercentFiling
2025-10-15Windsor Private Capital LP11.3%SCHEDULE 13D/A
2025-10-23Windsor Private Capital LP9.7%SCHEDULE 13D/A
2025-11-07Windsor Private Capital LP8.7%SCHEDULE 13D/A
2025-11-14Arena Investors, LP0%SCHEDULE 13G/A
2025-12-09Windsor Private Capital LP7.5%SCHEDULE 13D/A
2025-12-31Windsor Private Capital LP6.1%SCHEDULE 13D/A
2026-01-30Windsor Private Capital LP5%SCHEDULE 13D/A

Tools for this story

Each opens in a new tab, filled in for Firefly Neuroscience, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/firefly-neuroscience
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Firefly Neuroscience, Inc. 5%+ holders: 1 at 5% or more, largest Windsor Private Capital LP 5%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/firefly-neuroscience